slow responders to glp 1 Tell me in the comments if you’re a super responder, responder or non-responder. Hope this explanation helps. 💧💧💧#obesitymedicine #glp1 #glp1forweightloss #glp1medication #obesitydoctor GLP-1 Agonists and the Non-Responder

These effects are thought to be related to anti-inflammatory and antioxidant processes in the brain, as well as changes in neurotransmitters involved in mood regulation

Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase III trial

Higinbotham KG, Rice JM, Diwan BA, Kasprzak KS, Reed CD, Perantoni AO1992GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA.Cancer Res52474751 35

[DOI] [PMC free article] [PubMed] [Google Scholar] [27].Dayal S, Wilson KM, Motto DG, Miller FJ Jr, Chauhan AK, Lentz SR

Tirzepatide (Mounjaro) is the first approved medicine in this category, combining the actions of both incretin hormones

It is also active in the brain, where the receptors it binds to cluster in regions governing reward, motivation and stress the same circuitry that gets hijacked by addiction